{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:33:52Z","timestamp":1784082832828,"version":"3.55.0"},"reference-count":53,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,3,6]],"date-time":"2002-03-06T00:00:00Z","timestamp":1015372800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> P\u2010glycoprotein (P\u2010gp), lung resistance\u2010related protein (LRP) and multidrug resistance\u2010associated protein (MRP) expression, and blast cell intracellular daunorubicin accumulation (IDA) were evaluated in 95 previously untreated cases of adult acute lymphoblastic leukaemia (ALL) using flow cytometry. Forty\u2010five out of 95 (47%) patients were P\u2010gp positive (+), 12\/66 (18%) were LRP+ and 11\/66 (17%) were MRP+. Eighteen out of 66 (28%) patients showed a simultaneous multidrug resistance (MDR)\u2010related protein expression higher than controls for more than one protein, while 24\/66 (36%) cases did not overexpress any protein. Twenty\u2010one out of 24 (87%) cases overexpressing at least one MDR\u2010related protein had a defect in accumulating daunorubicin into their blast cells, while only 4\/24 (16%) cases who did not overexpress any protein had similar features. The complete remission rates were similar in MDR\u2010positive and \u2010negative (\u2013) patients but relapses within 6\u2003months were more frequent in P\u2010gp+ cases, and therefore the disease\u2010free survival duration was shorter in P\u2010gp+ than in P\u2010gp\u2013 patients (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b701). The number of MRP+ and\/or LRP+ cases was too small to be able to draw any conclusion on their role in affecting or predicting therapy outcome. In conclusion, P\u2010gp overexpression associated with a defect in daunorubicin accumulation is a frequent feature in adult ALL at onset and seems to be related to poorer therapy outcome and, consequently, a shorter disease\u2010free survival. LRP and MRP overexpression seems to be a rare event and no conclusion can be drawn on its prognostic role.<\/jats:p>","DOI":"10.1046\/j.0007-1048.2001.03322.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:42:44Z","timestamp":1047364964000},"page":"519-527","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["P\u2010glycoprotein, lung resistance\u2010related protein and multidrug resistance\u2010associated protein in <i>de novo<\/i> adult acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"116","author":[{"given":"Daniela","family":"Damiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Michelutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Michieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Masolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Stocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Geromin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ermacora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Fanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,3,6]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03312.x"},{"key":"e_1_2_6_3_1","first-page":"3267","article-title":"Proposed revised criteria for the classification of acute leukemia cells","volume":"79","author":"Bennet J.M.","year":"1985","journal-title":"Blood"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.6.2092.2092_2092_2098"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood.V79.2.473.473","article-title":"Clinical significance of multidrug resistance P\u2010glycoprotein expression on acute non lymphoblastic leukemia cells at diagnosis","volume":"79","author":"Campos L.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_6_1","first-page":"3135","article-title":"Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Group Fran\u00e7ais de Cytogenetique Hematologique","volume":"87","author":"Charrin C.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.11.2735.2735"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.9.9.3808"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1360704"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood.V85.5.1151.bloodjournal8551151","article-title":"The biology of acute lymphoblastic leukemia in adults","volume":"85","author":"Copelan E.A.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_11_1","volume-title":"The Analysis of Binary Data","author":"Cox D.R.","year":"1970"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509056834"},{"key":"e_1_2_6_13_1","first-page":"290","article-title":"P\u2010glycoprotein (P\u2010gp) and not lung resistance\u2010related protein (LRP) is a negative prognostic factor in secondary leukemias","volume":"83","author":"Damiani D.","year":"1998","journal-title":"Haematologica"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01378.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1182\/blood.V80.11.2729.2729","article-title":"Subpopulation of normal peripheral blood and bone marrow cell express a functional multidrug resistant phenotype","volume":"80","author":"Drach D.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.58.1.137"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(00)90018-0"},{"key":"e_1_2_6_18_1","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1182\/blood.V81.9.2394.2394","article-title":"Expression of the multidrug resistance\u2010associated P glycoprotein (P\u2010170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications","volume":"81","author":"Goasguen J.E.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609054866"},{"key":"e_1_2_6_20_1","first-page":"1000","article-title":"Decreased polyglutamylation of methotrexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease","volume":"7","author":"Goker E.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_6_21_1","first-page":"357","article-title":"Overexpression of multidrug resistance\u2010associated protein (MRP) increases resistance to natural products drugs","volume":"54","author":"Grant C.E.","year":"1994","journal-title":"Cancer Research"},{"key":"e_1_2_6_22_1","first-page":"258","article-title":"Expression of multidrug resistance\u2010associated protein (MRP) gene in acute myeloid leukemia (AML) (Abstract)","volume":"82","author":"Hart S.M.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_23_1","first-page":"12","article-title":"Aggressive chemotherapy of ALL in elderly patients","volume":"11","author":"Hoelzer D.","year":"1993","journal-title":"Hematological Oncology"},{"key":"e_1_2_6_24_1","first-page":"146","article-title":"Expression of P\u2010glycoprotein in de novo acute myelogenous leukemia at initial diagnosis: results of molecular and functional assays, and correlation with treatment outcome","volume":"8","author":"Ino T.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"e_1_2_6_26_1","first-page":"35","article-title":"Drug transport variant without P\u2010glycoprotein overexpression from a human squamous lung cancer cell line after selection with doxorubicin","volume":"1","author":"Kuiper C.M.","year":"1990","journal-title":"Journal of Cellular Pharmacology"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900901)66:5<868::AID-CNCR2820660510>3.0.CO;2-Z"},{"key":"e_1_2_6_28_1","first-page":"23","article-title":"Multidrug resistance: clinical relevance in acute leukemia","volume":"7","author":"List A.F.","year":"1993","journal-title":"Oncology"},{"key":"e_1_2_6_29_1","first-page":"1755","article-title":"Non P\u2010glycoprotein (P\u2010gp) mediated multidrug resistance (MDR): identification of a novel drug resistance phenotype with prognostic relevance in acute myeloid leukemia (AML) (Abstract)","volume":"82","author":"List A.F.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/81.1.55"},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/blood.V78.3.586.586","article-title":"Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlation with treatment outcome and in vitro drug sensitivity","volume":"78","author":"Marie J.P.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_32_1","first-page":"200","article-title":"Overexpression of MDR related p170 glycoprotein in chronic myeloid leukemia","volume":"70","author":"Michelutti A.","year":"1994","journal-title":"Haematologica"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1992.tb00571.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2020.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01172.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01957.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1991.tb00003.x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.10.708"},{"key":"e_1_2_6_40_1","first-page":"177","article-title":"P170 glycoprotein in multiple myeloma and acute leukemia","volume":"76","author":"Riccardi A.","year":"1991","journal-title":"Haematologica"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.1.365"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0695-578"},{"key":"e_1_2_6_43_1","first-page":"1475","article-title":"Over\u2010expression of a Mr 110,000 vesicular protein in non\u2010P\u2010glycoprotein\u2010mediated multidrug resistance","volume":"53","author":"Scheper R.J.","year":"1993","journal-title":"Cancer Research"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.1.186.bloodjournal851186"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2053.x"},{"key":"e_1_2_6_46_1","first-page":"592","article-title":"P\u2010glycoprotein expression and in vitro reversion of doxorubicin resistance by verapamil in clinical specimens from acute leukemia and lymphoma","volume":"5","author":"Solary E.","year":"1991","journal-title":"Leukemia"},{"key":"e_1_2_6_47_1","first-page":"1926","article-title":"Tissue distribution of P\u2010glycoprotein encoded by a multidrug resistant gene as revealed by a monoclonal antibody, MRK16","volume":"48","author":"Sugawara I.","year":"1988","journal-title":"Cancer Research"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.21.7735"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1988.tb01588.x"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-199708000-00003"},{"key":"e_1_2_6_51_1","first-page":"1870","article-title":"Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment","volume":"9","author":"Wattel E.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(90)90073-E"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb08305.x"},{"key":"e_1_2_6_54_1","first-page":"974","article-title":"P\u2010glycoprotein expression as unfavourable prognostic factor in acute myeloid leukemia","volume":"8","author":"Z\u00f6chbauer S.","year":"1994","journal-title":"Leukemia"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.0007-1048.2001.03322.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.0007-1048.2001.03322.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.0007-1048.2001.03322.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:51:43Z","timestamp":1697424703000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.0007-1048.2001.03322.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1046\/j.0007-1048.2001.03322.x"],"URL":"https:\/\/doi.org\/10.1046\/j.0007-1048.2001.03322.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]},"assertion":[{"value":"2002-03-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}